Dexcom Inc (NASDAQ:DXCM)
| 80.50 Delayed Data As of 4:01pm ET |  -1.60 / -1.95%Today’s Change | 66.89 Today|||52-Week Range 164.86 | -40.03% Year-to-Date |
Latest DXCM News | Press Releases
| 3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio 11:25am / Zacks.com - Paid Partner Content | Nasdaq Bear Market: 3 of the Best Growth Stocks to Buy Today Sep 22 / MotleyFool.com - Paid Partner Content |
| Better Growth Stock: Intuitive Surgical vs. DexCom Sep 28 / MotleyFool.com - Paid Partner Content | 3 Highly Profitable Stocks That Are Super Cheap Right Now Sep 21 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 82.10 |
| Today’s open | 82.59 |
| Day’s range | 80.44 - 83.98 |
| Volume | 66,265 |
| Average volume (3 months) | 3,094,261 |
| Market cap | $31.7B |
Data as of 4:01pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | -69.41% |
| Earnings growth (this year) | +19.81% |
| Earnings growth (next 5 years) | +38.45% |
| Revenue growth (last year) | +27.08% |
| P/E ratio | 192.8 |
| Price/Sales | 21.95 |
| Price/Book | 13.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BAXBaxter International... | -1.39 | -2.51% |
| ZBHZimmer Biomet Holdin... | -2.30 | -2.15% |
| WSTWest Pharmaceutical ... | -5.02 | -2.00% |
| PODDInsulet Corp | -1.90 | -0.82% |
Data as of 4:02pm ET, 09/30/2022
Financials
| Next reporting date | October 28, 2022 |
| EPS forecast (this quarter) | $0.24 |
| Annual revenue (last year) | $2.4B |
| Annual profit (last year) | $154.7M |
| Net profit margin | 6.32% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
